|Studied Disease||Clinical Data||Conclusions|
|Acne||Acne vulgaris/Rosacea open-label retrospective, cohort study examining the efficacy of Acunol® when used alone or in combination with other oral or topical therapies.||Acunol® demonstrates significant improvement in 4 weeks when used alone or in combination oral or topical therapies. Percent of patients with at least moderate improvement as measured by a subjective patient assessment.
% of Patients Improving: Using Acunol®
Only: 95% Using Acunol® + 1 or more Topical Medications: 85% Using Acunol® + Low Dose Oral Antibiotic: 95% Using Acunol® + Low Dose Oral Antibiotic + 1 or more Topical Medications: 88%